Therapeutic Evolution in mHSPC: Analyzing Emerging Combinations and Outcomes - CME - Guideline Central

CME

Title
Therapeutic Evolution in mHSPC: Analyzing Emerging Combinations and Outcomes
Link
Description
The goal of this activity is for learners to be better able to apply the latest clinical trial evidence to optimize treatment intensification and sequencing for patients with prostate cancer, from localized high-risk disease to mHSPC settings.
Target Audience
This educational activity is intended for an audience of oncologists, radiologists, urologists, nurses, pharmacists, and other members of the US and global prostate cancer care team.
Learning Objectives
  • Have increased knowledge regarding the
    • Biological rationale for early therapeutic intensification with combination strategies in the hormone-sensitive setting
    • Outcomes from recent pivotal trials evaluating androgen receptor (AR) pathway inhibitors in mHSPC
  • Have greater competence related to
    • Interpreting emerging trial data within the context of current treatment paradigms
  • Demonstrate greater confidence in their ability to
    • Individualize treatment strategies for patients with mHSPC using shared decision-making
Estimated Duration
60 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Radiology, Oncology, Urology
Keywords
hormone-sensitive, metastatic hormone-sensitive prostate cancer (mHSPC)
Disclosures and Disclaimers
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Accredited Providers
  • Medscape, LLC
Commercial Support
  • Bayer HealthCare Pharmaceuticals Inc
Activity Expiration Date
March 19, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1 CreditsACCME- Accreditation Council for Continuing Medical Education
Nursing1 Contact HoursANCC - American Nurses Credentialing Center
Pharmacy1 Contact HoursACPE- Accreditation Council for Pharmacy Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.